Bionano Genomics Operating Expenses Growth & History (BNGO)

Bionano Genomics's operating expenses was $46.5M for fiscal 2025.

View full Bionano Genomics company overview

Bionano Genomics annual operating expenses history

Bionano Genomics annual operating expenses

Fiscal yearPeriod endedOperating expensesChangeGrowth
20252025-12-31$46.5M−$57.8M−55.42%
20242024-12-31$104.4M−$120.4M−53.58%
20232023-12-31$224.8M$87.2M+63.33%
20222022-12-31$137.6M$56.7M+69.98%
20212021-12-31$81.0M$39.7M+95.95%
20202020-12-31$41.3M$12.1M+41.34%
20192019-12-31$29.2M$5.5M+23.34%
20182018-12-31$23.7M−$3.0M−11.20%
20172017-12-31$26.7M

Bionano Genomics operating expenses trends

Over the last five fiscal years, Bionano Genomics's operating expenses increased from $41.3M to $46.5M, a change of $5.2M. The latest reported quarter, Q2 2026, shows $11.5M.

About the metric

What operating expenses mean

Operating expenses are the recurring costs of running a company’s business beyond the direct costs used to calculate gross profit. They commonly include selling, general and administrative expenses, research and development, and other operating costs.

Calculation and source

SEC-reported and calculated operating expenses

TickerStat uses operating expenses reported in company SEC filings when available. When a separate total is unavailable, it calculates operating expenses as aligned gross profit minus operating income for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Bionano Genomics source filings ↗

Community posts

It’s quiet here.

No posts about BNGO yet. Start the conversation.

Write the first post